The purpose of this study is to investigate the effectiveness of Virtual Environment Desensitization (VED) in combating acrophobia (fear of heights). VED has the advantages of conducting time-consuming exposure therapy in the therapist's office and giving precise control of stimuli. Thus it may offer a time- and cost-effective mode of therapy, with implications for the treatment of many disorders, especially anxiety disorders. While the results of previous VED research projects have been consistently positive, this project will involve a much larger number of subjects, significantly increasing the confidence which can be attached to any positive findings. This study will also include is (Imaginal Systematic Desensitization) and PDW (Programmed Distance Writing) control groups in addition to the no-treatment control group used in the previous studies. Subjects will consist of at least 120 college undergraduates. They will undergo an extensive screening process to insure that they are suffering from acrophobia, and do not have any other serious physical or psychological conditions. Subjects' degree of fear anxiety will be measured using several subjective instruments; and physiological instruments will be used to measure various changes in bodily functions. Computer modeling will be created using Meme virtual reality development software package to develop several virtual reality development software package to develop several virtual reality scenes for VED group. The treatment schedule will consist of eight weekly sessions for the IS, PDW, and VED conditions. Assessment measures will be administered to all subjects pre-treatment, post-treatment, and one month post-treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Minority Biomedical Research Support - MBRS (S06)
Project #
5S06GM008247-13
Application #
6347550
Study Section
Minority Programs Review Committee (MPRC)
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
Budget End
Support Year
13
Fiscal Year
2000
Total Cost
$69,492
Indirect Cost
Name
Clark Atlanta University
Department
Type
DUNS #
065325177
City
Atlanta
State
GA
Country
United States
Zip Code
30314
Ifere, Godwin O; Equan, Anita; Gordon, Kereen et al. (2010) Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene. Cancer Epidemiol 34:461-71
Mariam, Yitbarek H; Musin, Ryza N (2008) Transition from moderate to strong hydrogen bonds: its identification and physical bases in the case of O-H...O intramolecular hydrogen bonds. J Phys Chem A 112:134-45
Kimbro, K Sean; Duschene, Kaitlin; Willard, Margeret et al. (2008) A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment. Mol Biol Rep 35:23-7
Chu, Qinghui; Pang, Yi (2004) Vibronic structures in the electronic spectra of oligo(phenylene ethynylene): effect of m-phenylene to the optical properties of poly(m-phenylene ethynylene). Spectrochim Acta A Mol Biomol Spectrosc 60:1459-67
Sannigrahi, Biswajit; McGeady, Paul; Khan, Ishrat M (2004) Helical poly(3-methyl-4-vinylpyridine)/amino acid complexes: preparation, characterization, and biocompatibility. Macromol Biosci 4:999-1007
Liang, Sidney; Bu, Xiu R (2002) Tertiary pentyl groups enhance salen titanium catalyst for highly enantioselective trimethylsilylcyanation of aldehydes. J Org Chem 67:2702-4
Vanderveer, Donald; Colon, Marisabel Lebron; Bu, Xiu R (2002) Crystal structure of a chiral Ni complex: (R,R)-N,N'-bis(3-t-butylsalicylidene)-1,2-cyclohexanediaminonickel(II). Anal Sci 18:1283-4
Musey, Paul I; Ibim, Sobrasua M; Talukder, Niranjan K (2002) Development of artificial blood vessels: seeding and proliferation characteristics of endothelial and smooth muscle cells on biodegradable membranes. Ann N Y Acad Sci 961:279-83
Chiang, C F; Okou, D T; Griffin, T B et al. (2001) Green fluorescent protein rendered susceptible to proteolysis: positions for protease-sensitive insertions. Arch Biochem Biophys 394:229-35
Johnson, K P; Rowe, G C; Jackson, B A et al. (2001) Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP. Cell Mol Biol (Noisy-le-grand) 47:1039-45

Showing the most recent 10 out of 17 publications